Taselisib (GDC 0032)

Inquiry

Cat. No.: DIA-0230180

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	1282512-48-4
Synonyms	RG7604
Formula	C₂₄H₂₈N₈O₂
Molecular Weight	460.53
SMILES	CC(C)[N]1N=C(C)N=C1C2=C[N]3CCOC4=CC(=CC=C4C3=N2)C5=C[N](N=C5)C(C)(C)C(N)=O
Target	PI3Kβ
Product Description	Taselisib (GDC 0032) is a potent, next-generation β isoform-sparing PI3K inhibitor targeting PI3Kα/δ/γ with Ki of 0.29 nM/0.12 nM/0.97nM, >10 fold selective over PI3Kβ.

Format & Storage
Purity	> 98%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.